Basic information Safety Supplier Related

CDK9-PROTAC

Basic information Safety Supplier Related

CDK9-PROTAC Basic information

Product Name:
CDK9-PROTAC
Synonyms:
  • CDK9-PROTAC
  • PROTAC 6
  • PROTAC CDK9 DEGRADER-1
  • N-(5-Cyclobutyl-1H-pyrazol-3-yl)-2-(4-((5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)pentyl)oxy)phenyl)acetamide
  • Benzeneacetamide, N-(5-cyclobutyl-1H-pyrazol-3-yl)-4-[[5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]pentyl]oxy]-
  • N-(5-cyclobutyl-1H-pyrazol-3-yl)-2-{4-[(5-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy}pentyl)oxy]phenyl}acetamide
CAS:
2118356-96-8
MF:
C33H35N5O7
MW:
613.66
Mol File:
2118356-96-8.mol
More
Less

CDK9-PROTAC Chemical Properties

Boiling point:
947.1±65.0 °C(Predicted)
Density 
1.390±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO : ≥ 104 mg/mL (169.47 mM)
form 
Solid
pka
10.70±0.40(Predicted)
color 
White to off-white
More
Less

CDK9-PROTAC Usage And Synthesis

Uses

CDK9-PROTAC can be used as a selective CDK9 degrader.

Biological Activity

PROTAC CDK9 Degrader-1 is a selective CDK9 degrader.

in vitro

PROTAC CDK9 Degrader-1 (Compound 3; 2.5-20 μM; 6 hours) degrades CDK9 in a dose dependent manner in HCT116 cells.

Western Blot Analysis

Cell Line: HCT116 cells
Concentration: 2.5, 5, 10, and 20μM
Incubation Time: 6 hours
Result: Degraded CDK9 in a dose dependent manner .

target

CDK9

CDK9-PROTACSupplier

Sichuan Wei Keqi Biological Technology Co., Ltd.
Tel
028-81700200 18116577057
Email
3003855609@qq.com
Beijing Jin Ming Biotechnology Co., Ltd.
Tel
010-60605840 18892239720
Email
psaitong@jm-bio.com
Shanghai finete Pharmaceutical Co., Ltd.
Tel
021-021-00000000 18221039705
Email
finetechpharm@126.com
Fan De(Beijing) Biotechnology Co., Ltd.
Tel
15911056312
Email
liming@bio-fount.com
Jilin Province Woda Biotechnology Co., Ltd.
Tel
13504435624
Email
1927928688@qq.com